About CR
Contact Us
Subscribe
Send Letter to Editor
HOME | CURRENT ISSUE | ARCHIVES | SUPPLEMENTS | CME | MAINTAINING CERTIFICATION | RESOURCES

Diabetes: Case Report


Issue: July 2008
Article Tools
Email This Article
Reprint This Article
Write the Editor

Metformin treatment in a patient with metabolic syndrome


A 43-year-old man with a strong family history of diabetes mellitus presented to his primary care physician requesting interventions to decrease his cardiovascular risk. He was actively working on intensive lifestyle modifications, such as diet and exercise, with minimal success. The patient was overweight, with a body mass index (BMI) of 29 kg/m2 and a waist circumference of 108 cm. His blood pressure was mildly elevated, at 140/86 mm Hg. His lipid values were as follows: total cholesterol, 175 mg/dL; triglycerides, 281 mg/dL; high-density lipoprotein (HDL) cholesterol, 35 mg/dL; and calculated low-density lipoprotein (LDL) cholesterol, 135 mg/dL. His fasting plasma glucose level on 2 occasions was 101 mg/dL and 109 mg/dL.

The physician explained to the patient that he met the criteria for metabolic syndrome and was at significant risk for developing type 2 diabetes. Treatment with 850 mg of metformin (Fortamet, Glucophage, Riomet) twice daily was recommended, in addition to continuing intensive lifestyle interventions. After 6 months of treatment, the patient had lost weight, reduced his BMI to 26 kg/m2, and decreased his waist circumference to 99 cm. Laboratory evaluation showed an HDL cholesterol level of 37 mg/dL, a calculated LDL cholesterol level of 128 mg/dL, and a fasting glucose level of 95 mg/dL. The patient chose to continue with this treatment plan, demonstrating similar weight and laboratory values 1 year later.


Related Articles - Diabetes

A systematic review of metformin treatment in persons at risk for diabetes mellitus - July 2008

Should metformin be used to prevent diabetes in high-risk patients? - July 2008

Coronary artery disease in asymptomatic diabetic patients - May 2007

Risk factors for coronary artery disease: real clues to early detection? - May 2007

Effect of medication nonadherence in diabetes mellitus - April 2007

Displaying 5 of 13 related articles. View all related articles.


Article Tools
Email This Article
Reprint This Article
Write the Editor
Search
   
Resources
Media Kit
Author Guidelines
Editorial Advisory Board
Reprints

Advertisement
Current Issue | Archives | Supplements | CME | Maintaining Certification | Resources
About CR | Contact Us | Subscribe | Send Letter to Editor
Media Kit | Author Guidelines | Editorial Advisory Board | Reprints
Other Healthcare Publications
The American Journal of Managed Care |  Cardiology Review |  Family Practice Recertification |  Internal Medicine World Report |  Pharmacy Times
Physician's Money Digest |  Resident & Staff |  Surgical Rounds